HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 182 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,887,224 | -6.9% | 271,200 | 0.0% | 1.25% | -10.7% |
| Q2 2023 | $9,543,528 | -9.0% | 271,200 | -15.6% | 1.40% | -10.1% |
| Q1 2023 | $10,487,180 | -32.3% | 321,200 | +14.2% | 1.56% | -30.6% |
| Q4 2022 | $15,494,120 | +12.8% | 281,200 | -9.3% | 2.25% | +33.7% |
| Q3 2022 | $13,730,000 | -6.2% | 310,000 | +3.3% | 1.68% | -24.1% |
| Q2 2022 | $14,631,000 | +0.2% | 300,000 | 0.0% | 2.22% | -24.0% |
| Q1 2022 | $14,595,000 | – | 300,000 | – | 2.92% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $366,268,777 | 96.46% |
| venBio Partners LLC | 1,035,396 | $33,805,679 | 18.74% |
| Nan Fung Group Holdings Ltd | 368,665 | $12,036,912 | 8.19% |
| Vivo Capital, LLC | 2,606,247 | $85,093,965 | 5.90% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 570,500 | $18,621,120 | 5.20% |
| ASHFORD CAPITAL MANAGEMENT INC | 445,418 | $14,542,898 | 2.18% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 678,715 | $22,160,045 | 2.07% |
| TANG CAPITAL MANAGEMENT LLC | 321,200 | $10,487,180 | 1.56% |
| AlphaCentric Advisors LLC | 67,500 | $2,203,875 | 1.52% |
| Paradiem, LLC | 66,995 | $2,187,387 | 0.68% |